Home > Investor > Financial Highlights > Revenues by country

Revenues by country

Distribution of sales revenues by geographic region 
 %
Europe 33
Bulgaria  65
Other 2

The contribution of sales in Bulgaria to the consolidated sales revenue in the first half of 2020 amounted to 65%, increasing by 10% compared to the first half of 2019. Sopharma has a 3% share on the Bulgarian pharmaceutical market in terms of value and a 10 % share in terms of sold quantity (units):

  • Novartis: 6.6% (3.6% in units)
  • Roche: 6.8% (0.3 in units)
  • Actavis: 4.3% (9% in units)
  • GlaxoSmithKlein: 2.9% (2.4% in units)
  • Abbvie: 3.8% (0% in units)
  • Sanofi-Aventis: 2.6% (2% in units)
  • Astra Zeneca: 2.8% (0.4% in units)
  • Pfizer: 4% (1% in units)
  • Merck: 4.2% (0.8% in units)